Opa binding to cellular CD66 receptors mediates the transcellular traversal of Neisseria gonorrhoeae across polarized T84 epithelial cell monolayers.
We have analysed the capacity of the 11 phase-variable, opacity-associated (Opa) proteins encoded by Neisseria gonorrhoeae MS11 to mediate traversal across polarized monolayers of the human colonic carcinoma T84 cell line. Gonococci expressing either the heparan sulphate proteoglycan (HSPG) binding Opa protein (Opa50) or no Opa protein (Opa-) did not interact with the apical pole of T84 monolayers, whereas the 10 variant Opa proteins previously shown to bind CD66 receptors were found to mediate efficient gonococcal adherence and transepithelial traversal. Consistent with this, T84 cells were shown by reverse transcriptase-polymerase chain reaction (RT-PCR) and immunoblotting to co-express CD66a (BGP), CD66c (NCA) and CD66e (CEA). The recruitment of CD66 receptors by Opa-expressing gonococci indicates their involvement in mediating adherence to the surface of T84 cells, and these bacterial interactions could be inhibited completely using polyclonal antibodies cross-reacting with all of the CD66 proteins co-expressed on T84 cells. Consistent results were obtained when Opa proteins were expressed in Escherichia coli, suggesting that the Opa-CD66 interaction is sufficient to mediate bacterial traversal. Transcytosis of Opa-expressing N. gonorrhoeae or E. coli did not disrupt the barrier function of infected monolayers, as indicated by a sustained transepithelial electrical resistance (TEER) throughout the course of infection, and confocal laser scanning and electron microscopy both suggest a transcellular rather than a paracellular route of traversal across the monolayers. Parallels between the results seen here and previous work done with organ cultures confirm that T84 monolayers provide a valid model for studying neisserial interactions with the mucosal surface, and suggest that CD66 receptors contribute to this process in vivo.
Wang
J
J
Max-Planck-Institut für Biologie, Abteilung Infektionsbiologie, Spemannstrasse 34, D-72076 Tübingen, Germany.
Gray-Owen
S D
SD
Knorre
A
A
Meyer
T F
TF
Dehio
C
C
D000906:Antibodies / Q000494:pharmacology; D000942:Antigens, Bacterial / Q000378:metabolism*; D015703:Antigens, CD / Q000276:immunology / Q000378:metabolism*; D000943:Antigens, Differentiation / Q000276:immunology / Q000378:metabolism*; D001422:Bacterial Adhesion / Q000502:physiology; D001424:Bacterial Infections / Q000382:microbiology; D015815:Cell Adhesion Molecules; D002462:Cell Membrane / Q000648:ultrastructure; D004705:Endocytosis / Q000502:physiology; D004926:Escherichia coli / Q000235:genetics; D005455:Fluorescent Antibody Technique; D015964:Gene Expression Regulation, Bacterial / Q000235:genetics; D006801:Humans; D018613:Microscopy, Confocal; D008854:Microscopy, Electron; D009344:Neisseria gonorrhoeae / Q000378:metabolism / Q000472:pathogenicity*; D012333:RNA, Messenger / Q000235:genetics; D011956:Receptors, Cell Surface / Q000378:metabolism; D013997:Time Factors; D014407:Tumor Cells, Cultured
D000906:Antibodies; D000942:Antigens, Bacterial; D015703:Antigens, CD; D000943:Antigens, Differentiation; C069847:CD66 antigens; D015815:Cell Adhesion Molecules; D012333:RNA, Messenger; D011956:Receptors, Cell Surface; C050308:opacity proteins